Schedule 13G ownership disclosure
ADAMAS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 00548A106
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,241,239
- Percent of class
- 8.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-20-000104
- Form type
- SC 13G
- Filer
- Adamas Pharmaceuticals Inc
- CIK
- CIK 1328143
- Filed
- Feb 13, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership